Back to mobile site

More on IVVD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.3% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Invivyd (NQ:IVVD)
Delayed: 0.94 -0.03 (3.09%)
Prev. Close $0.97  
Open$0.96 
52 Wk High$ 
52 Wk Low$ 
Day High$0.99 
Day Low$0.92 
P/E N/A  
EPS$ 
Volume3,280,745 


Jun 16, 2026 07:01 AM INVIVYD completes enrollment in Phase 3 COVID antibody trial
Jun 16, 2026 07:01 AM Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Jun 16, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Jun 9, 2026 07:01 AM Invivyd begins Phase 3 trial comparing COVID antibody to mRNA vaccine
Jun 9, 2026 07:01 AM Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safe
Jun 3, 2026 07:01 AM Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 1, 2026 07:02 AM Invivyd completes enrollment in phase 3 COVID antibody trial
Jun 1, 2026 07:01 AM Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
May 27, 2026 07:01 AM Invivyd to Participate in Upcoming Investor Events
May 21, 2026 04:50 PM Form 4 Invivyd, Inc. For: May 19 Filed by: Royan Ajay
View All Articles

Entities mentioned with IVVD

View All Entities